NVNO Envveno Medical Corp: company enters the second half of 2026 with tailwinds from an FDA ide approval - Tavve pivotal study expected to
NVNO Envveno Medical Corp: company enters the second half of 2026 with tailwinds from an FDA ide approval - Tavve pivotal study expected to begin enrolling patients during the second half of this year
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.